A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases Academic Article uri icon

Overview

MeSH Major

  • Liver Neoplasms
  • Radiotherapy, Conformal

abstract

  • Biologically potent doses of SBRT are well tolerated in patients with limited liver metastases. Results of this study form the basis for an ongoing Phase II SBRT study of 60 Gy over three fractions for liver metastases.

publication date

  • August 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2005.01.002

PubMed ID

  • 16029795

Additional Document Info

start page

  • 1371

end page

  • 8

volume

  • 62

number

  • 5